Format

Send to

Choose Destination
Br J Cancer. 2017 Jun 6;116(12):1551-1557. doi: 10.1038/bjc.2017.129. Epub 2017 May 18.

GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.

Author information

1
NHS Bowel Cancer Screening Programme Southern Hub, Surrey Pathology Services, 20 Priestley Road, Surrey Research Park, Guildford, Surrey, GU2 7YS, UK.
2
Department of Biochemistry and Physiology, University of Surrey, Guildford, Surrey GU2 7XH, UK.
3
Wessex Cancer Clinical Network, Oakley Road, Southampton, Hampshire SO16 4GX, UK.
4
The Whiteley Surgery, Yew Tree Drive, Whiteley, Fareham PO15 7LB, UK.
5
Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London EC1M 6BQ, UK.

Abstract

BACKGROUND:

The NHS Bowel Cancer Screening Programme (BCSP) in England does not involve general practitioners (GPs). Uptake is ∼58%. The Practice Endorsed Additional Reminder Letter (PEARL) study piloted a GP-endorsed reminder letter.

METHODS:

General practices in Wessex with uptake <55% (prevalent invitations) were invited to participate. Subjects who had been invited for screening, sent a standard 28-day BCSP reminder letter but had not returned a test kit within 30 days of the standard reminder were sent a second reminder letter bearing the GP's letterhead and signature. Uptake was compared between PEARL and non-PEARL practices by standardised uptake ratio (standardised for prior prevalent uptake and other confounders). In addition, 25 non-PEARL practices were matched with PEARL practices for prior prevalent uptake and number of invitees.

RESULTS:

Twenty-five practices agreed to participate. A total of 3149 GP-endorsed reminders were sent. Uptake in the PEARL practices was 54% compared with 51% in the matched-control practices. The adjusted RR for uptake was 1.08 (95% CI: 1.05, 1.11, P<0.001) for all invitees and 2.18 (1.79, 2.66, P<0.001) for invitees who had not returned a kit following the standard reminder.

CONCLUSIONS:

The GP-endorsed reminder was associated with significantly increased uptake among subjects not responding to the standard reminder letter.

PMID:
28524157
PMCID:
PMC5518858
DOI:
10.1038/bjc.2017.129
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center